176 related articles for article (PubMed ID: 36084796)
21. Muscle Strength Gain is Positively Associated with Functional Recovery in Patients with Sarcopenic Obesity After Stroke.
Nagano F; Yoshimura Y; Matsumoto A; Bise T; Kido Y; Shimazu S; Shiraishi A
J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106429. PubMed ID: 35381428
[TBL] [Abstract][Full Text] [Related]
22. Impact of EASO/ESPEN-Defined Sarcopenic Obesity Following a Technology-Based Weight Loss Intervention.
Wood BS; Batchek DJ; Lynch DH; Spangler HB; Gross DC; Petersen CL; Batsis JA
Calcif Tissue Int; 2024 Jan; 114(1):60-73. PubMed ID: 37758867
[TBL] [Abstract][Full Text] [Related]
23. Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.
Gortan Cappellari G; Semolic A; Zanetti M; Vinci P; Ius M; Guarnieri G; Busetto L; Donini LM; Barazzoni R
Metabolism; 2023 Aug; 145():155595. PubMed ID: 37245728
[TBL] [Abstract][Full Text] [Related]
24. Understanding factors associated with sarcopenic obesity in older African women from a low-income setting: a cross-sectional analysis.
Mendham AE; Goedecke JH; Micklesfield LK; Brooks NE; Faber M; Christensen DL; Gallagher IJ; Lundin-Olsson L; Myburgh KH; Odunitan-Wayas FA; Lambert EV; Kalula S; Hunter AM
BMC Geriatr; 2021 Apr; 21(1):247. PubMed ID: 33853546
[TBL] [Abstract][Full Text] [Related]
25. Neck circumference as a potential indicator of pre-sarcopenic obesity in a cohort of community-based individuals.
Xu Y; Li X; Hu T; Shen Y; Xiao Y; Wang Y; Bao Y; Ma X
Clin Nutr; 2024 Jan; 43(1):11-17. PubMed ID: 37992633
[TBL] [Abstract][Full Text] [Related]
26. Sarcopenic Obesity in Chronic Kidney Disease: Challenges in Diagnosis Using Different Diagnostic Criteria.
Bellafronte NT; de Queirós Mattoso Ono A; Chiarello PG
Med Princ Pract; 2021; 30(5):477-486. PubMed ID: 34082433
[TBL] [Abstract][Full Text] [Related]
27. Sarcopenic obesity in community-dwelling older women, determined by different diagnostic methods.
Oliveira TM; Roriz AKC; Barreto-Medeiros JM; Ferreira AJF; Ramos L
Nutr Hosp; 2019 Dec; 36(6):1267-1272. PubMed ID: 31610674
[TBL] [Abstract][Full Text] [Related]
28. Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: The Bunkyo Health Study.
Someya Y; Tamura Y; Kaga H; Sugimoto D; Kadowaki S; Suzuki R; Aoki S; Hattori N; Motoi Y; Shimada K; Daida H; Ishijima M; Kaneko K; Nojiri S; Kawamori R; Watada H
Clin Nutr; 2022 May; 41(5):1046-1051. PubMed ID: 35390728
[TBL] [Abstract][Full Text] [Related]
29. Sarcopenic Obesity and Activities of Daily Living in Stroke Rehabilitation Patients: A Cross-Sectional Study.
Matsushita T; Nishioka S; Taguchi S; Yamanouchi A; Nakashima R; Wakabayashi H
Healthcare (Basel); 2020 Aug; 8(3):. PubMed ID: 32781673
[TBL] [Abstract][Full Text] [Related]
30. Sarcopenic Obesity: Time to Meet the Challenge.
Barazzoni R; Bischoff S; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
Obes Facts; 2018; 11(4):294-305. PubMed ID: 30016792
[TBL] [Abstract][Full Text] [Related]
31. Specific bioelectrical vectors pattern in individuals with sarcopenic obesity.
Marini E; Sulis S; Vorobel'ová L; Stagi S
Clin Nutr; 2024 Mar; 43(3):620-628. PubMed ID: 38306890
[TBL] [Abstract][Full Text] [Related]
32. Sarcopenic obesity: Time to meet the challenge.
Barazzoni R; Bischoff SC; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
Clin Nutr; 2018 Dec; 37(6 Pt A):1787-1793. PubMed ID: 29857921
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.
Kemmler W; von Stengel S; Engelke K; Sieber C; Freiberger E
Osteoporos Int; 2016 Jan; 27(1):275-81. PubMed ID: 26318759
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and diagnostic agreement of sarcopenic obesity with different definitions among Chinese community-dwelling older adults.
Mo YH; Yang C; Su YD; Dong X; Deng WY; Liu BB; Yao XM; Wang XH
Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35077561
[TBL] [Abstract][Full Text] [Related]
35. Assessment of phase angle as a novel indicator for sarcopenic obesity according to the ESPEN/EASO criteria in older adults with diabetes mellitus.
Hafızoğlu M; Yıldırım HK; Öztürk Y; Şahiner Z; Karaduman D; Atbaş C; Doğu BB; Halil MG; Cankurtaran M; Balcı C
Nutrition; 2024 Jul; 123():112412. PubMed ID: 38554459
[TBL] [Abstract][Full Text] [Related]
36. Associations of sarcopenic obesity versus sarcopenia alone with functionality.
Bahat G; Kilic C; Ozkok S; Ozturk S; Karan MA
Clin Nutr; 2021 May; 40(5):2851-2859. PubMed ID: 33940398
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria.
Lera L; Albala C; Sánchez H; Angel B; Hormazabal MJ; Márquez C; Arroyo P
J Frailty Aging; 2017; 6(1):12-17. PubMed ID: 28244552
[TBL] [Abstract][Full Text] [Related]
38. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004.
Batsis JA; Mackenzie TA; Lopez-Jimenez F; Bartels SJ
Nutr Res; 2015 Dec; 35(12):1031-9. PubMed ID: 26472145
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of sarcopenic obesity in adults with end-stage knee osteoarthritis.
Godziuk K; Prado CM; Woodhouse LJ; Forhan M
Osteoarthritis Cartilage; 2019 Dec; 27(12):1735-1745. PubMed ID: 31276820
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria.
Remelli F; Maietti E; Abete P; Bellelli G; Bo M; Cherubini A; Corica F; Di Bari M; Maggio M; Rizzo MR; Rossi AP; Landi F; Volpato S;
Aging Clin Exp Res; 2022 Jan; 34(1):113-120. PubMed ID: 34398439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
